Skip to search formSkip to main contentSkip to account menu

Infant Acute Lymphoblastic Leukemia

An acute lymphoblastic leukemia that occurs in infancy.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Purpose of review The prognosis for infants less than 12 months of age who are diagnosed with acute lymphoblastic leukemia (ALL… 
2010
2010
Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment 
2010
2010
Introduction Infant acute lymphoblastic leukemia (ALL) is considered a high-risk entity. Patients diagnosed in the first 3 months… 
2006
2006
Little progress has been made in improving the survival of infants with high-risk acute lymphoblastic leukemia (ALL).[1][1],[2][2… 
2006
2006
The antimetabolite cytosine arabinoside (Ara-C) is a deoxycytidine analog that is used as a therapeutic agent in many leukemia… 
2005
2005
Acute lymphoblastic leukemia (ALL) in infants is characterized by rearrangements of the mixed lineage leukemia (MLL) gene, drug… 
2003
2003
Abstract: Fas (APO‐1/CD95) is a 45‐kDa membrane protein which regulates apoptosis in many lymphoid cell types. In the present… 
2002
2002
Infant acute lymphoblastic leukemia (ALL) is characterized by the presence of the proB phenotype (CD10−/CD19+), poor prognosis… 
2001
2001
Childhood acute lymphoblastic leukemia (ALL) is frequently initiated in utero at a time of developmentally regulated insertion of… 
Highly Cited
1999
Highly Cited
1999
Infant acute lymphoblastic leukemia (ALL) with MLL gene rearrangements is characterized by early pre-B phenotype (CD10(-)/CD19…